News

The company’s novel approach uses stem cells harvested from the patient’s bone marrow into which a healthy version of the disease causing gene is inserted. After being grown

Hebei Aoxing API Pharmaceutical is a joint venture (JV) between Hebei Aoxing Pharmaceutical Group, a subsidiary of Aoxing Pharma and Macfarlan Smith, a subsidiary of Johnson Matthey. Naloxone

Adeona is developing reaZin, a product candidate for the dietary management of Alzheimer’s disease and mild cognitive impairment, as a prescription medical food. reaZin, formerly named Zinthionein, is

The trial is planned to investigate the safety and efficacy of dalbavancin to vancomycin, with patients randomized to vancomycin allowed to switch to oral linezolid after three days

Study of V-101 is a randomized, multi-centered, double-blinded, vehicle-controlled, Phase II clinical trial designed to evaluate the dose-response relationship of two concentrations of V-101 cream vs. vehicle (placebo).

The fund will also be used for completing Phase II testing of its house dust mite and grass allergy T-cell vaccines, based on its proprietary ToleroMune technology. The

The patent entitled, ‘Pharmaceutical Compositions for the Treatment of Pain,’ covers a method of treating cancer related pain by administering a combination of the cannabinoids cannabidiol (CBD) and

The new disposable filling system concept was developed in cooperation with a strategic partner for disposable materials. Using a holistic approach, flow behavior, interfaces, tubing layout, distribution and

Based on their small particle size of approximately 20 nanometers, sLNPs have the potential for broadened biodistribution beyond liver delivery. Alnylam chief scientific officer Kenneth Koblan said they